Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Orthofix Medical Inc. (OFIX:NASDAQ), powered by AI.
Orthofix Medical Inc. is currently trading at $9.41. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Orthofix Medical Inc. on Alpha Lenz.
Orthofix Medical Inc.'s P/E ratio is -4.0.
“Orthofix Medical Inc. trades at a P/E of -4.0 (undervalued) with modest ROE of -19.3%. 3Y revenue CAGR of 21.3% highlights clear growth momentum.”
Ask for details →Orthofix Medical Inc. is a global medical device company that specializes in the development, manufacture, and distribution of reconstructive and regenerative orthopedic and spine solutions. The primary function of Orthofix Medical is to provide innovative technologies that enhance the treatment of patients with a variety of musculoskeletal conditions. Its product offerings include spine fixation, regenerative biologics, bone growth stimulation, and orthopedic solutions, catering to practitioners and health providers working within the fields of orthopedics and spine surgery. The company's impact spans across several sectors within the healthcare industry, particularly in enhancing patient recovery and improving surgical outcomes. Headquartered in Lewisville, Texas, Orthofix Medical holds a significant role in the market by continuously advancing medical technologies and contributing to the growing field of orthopedic and spine care. The firm's commitment to research and development ensures a pipeline of solutions that meet the evolving needs of clinicians and patients worldwide, reinforcing its importance in advancing health outcomes through innovative medical devices.
“Orthofix Medical Inc. trades at a P/E of -4.0 (undervalued) with modest ROE of -19.3%. 3Y revenue CAGR of 21.3% highlights clear growth momentum.”
Ask for details →Orthofix Medical Inc. (ticker: OFIX) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 1,616 employees. Market cap is $373M.
The current price is $9.41 with a P/E ratio of -4.04x and P/B of 0.83x.
ROE is -19.34% and operating margin is -10.04%. Annual revenue is $822M.